1995年至今，共以通讯作者署名发表SCI论文125篇（IF=278.75），被他引502次（IF=2797.74）。合作署名发表SCI论文22篇（IF=99.06），他引 223次。并以第一发明人获中国发明专利21项（实施1项），国际发明专利13项。
Since 1995, Professor Long Yu has published 125 SCI papers (IF = 278.75) as corresponding author, and the total citation number is 502 (IF = 2797.74); coauthored in 22 SCI papers (IF = 99.06) with the total citation number as 223 (IF = 1136.96). Moreover, as first inventor, Professor Yu has been granted with 21 Chinese patents (1 has been implemented) and 13 international patents.
1.      Wu Y, Zuo J, Ji G, Saiyin H, Liu X, Yin F, Cao N, Wen Y, Li JJ, Yu L*. (2009).Proapoptotic function of integrin beta(3) in human hepatocellular carcinoma cells. Clin Cancer Res. Jan 1;15(1):60-9.
2.      Pei Y, Zhu P, Dang Y, Wu J, Yang X, Wan B, Liu JO., Yi Q, Yu L*. Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser(647) in response to CD28 costimulation. J Immunol. 180(1):222-229.
3.      Liu X, He Q, Studholme DJ, Wu Q, Liang S, Yu L*. NCD3G: a novel nine-cysteine domain in family 3 GPCRs. Trends Biochem Sci. 29(9):458-61.
4.      Guo J, Chen S, Huang C, Chen L, Studholme D, Zhao S, Yu L*. MANSC: a seven-cysteine-containing domain present in animal membrane and extracellular proteins. Trends Biochem Sci. 29(4):172-174.
5.      He H, Dang Y, Dai F, Guo Z, Wu J, She X, Pei Y, Chen Y, Ling W, Wu C, Zhao S, Liu JO, Yu L*. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem. 278(31):29278-29287.